Published in Lepr Rev on September 01, 2004
Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols. BMC Neurol (2012) 0.80
Anti-sarcopenic effects of diamino-diphenyl sulfone observed in elderly female leprosy survivors: a cross-sectional study. J Cachexia Sarcopenia Muscle (2015) 0.75
An orthopedic-, surgical-, and epidemiological-based investigation of leprosy, in the Tamil Nadu state of India. Adv Orthop (2012) 0.75
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet (2010) 5.02
Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med (2010) 3.04
Beliefs and attitudes toward Buruli ulcer in Ghana. Am J Trop Med Hyg (2002) 2.30
Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clin Infect Dis (2005) 1.95
Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis (2003) 1.84
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients. Eur Respir J (2013) 1.75
Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation. J Infect Dis (2005) 1.64
Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection. Clin Infect Dis (2011) 1.58
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis. Eur Respir J (2013) 1.58
Quality of interhospital transport of critically ill patients: a prospective audit. Crit Care (2005) 1.57
Functional limitations after surgical or antibiotic treatment for Buruli ulcer in Benin. Am J Trop Med Hyg (2009) 1.49
Inhibition of p38 mitogen-activated protein kinase: dose-dependent suppression of leukocyte and endothelial response after endotoxin challenge in humans. Crit Care Med (2002) 1.49
Pandemic influenza and hospital resources. Emerg Infect Dis (2007) 1.44
Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis (2009) 1.43
Pandemic influenza and pediatric intensive care. Pediatr Crit Care Med (2010) 1.42
Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic. J Clin Microbiol (2003) 1.33
Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members. Trans R Soc Trop Med Hyg (2008) 1.32
Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med Int Health (2005) 1.29
Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr (2010) 1.27
Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1). BMJ (2004) 1.20
Prone positioning of patients with acute respiratory failure. N Engl J Med (2002) 1.18
Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients. Intensive Care Med (2010) 1.18
Buruli ulcer: differences in treatment outcome between two centres in Ghana. Acta Trop (2003) 1.11
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana. Clin Diagn Lab Immunol (2005) 1.11
Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged > or =65 years in the Netherlands. Clin Ther (2010) 1.09
Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Trop Med Int Health (2003) 1.07
Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice. AIDS (2014) 1.07
Optimization of standard in-house 24-locus variable-number tandem-repeat typing for Mycobacterium tuberculosis and its direct application to clinical material. J Clin Microbiol (2014) 1.07
Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol (2009) 1.05
Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Ther Drug Monit (2010) 0.99
Ultrasound of the lung: just imagine. Intensive Care Med (2003) 0.99
Omeprazole significantly reduces posaconazole serum trough level. Clin Infect Dis (2009) 0.99
Development and validation of a severity scale for leprosy type 1 reactions. PLoS Negl Trop Dis (2008) 0.98
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients. Clin Pharmacokinet (2010) 0.98
Epidemiology of acute lung injury and acute respiratory distress syndrome in The Netherlands: a survey. Respir Med (2007) 0.98
A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana. Am J Trop Med Hyg (2010) 0.97
Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission. Trans R Soc Trop Med Hyg (2005) 0.97
Predicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study. PLoS Negl Trop Dis (2009) 0.95
An 18-year-old man with rapidly progressive multiorgan failure after a positive mononucleosis spot test result. Chest (2006) 0.95
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis. Eur Respir J (2012) 0.93
Clarithromycin significantly increases linezolid serum concentrations. Antimicrob Agents Chemother (2010) 0.92
Comparison of 14 molecular assays for detection of Mycobacterium tuberculosis complex in bronchoalveolar lavage fluid. J Clin Microbiol (2013) 0.92
Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal. Trans R Soc Trop Med Hyg (2004) 0.90
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines. Med Microbiol Immunol (2012) 0.90
Interventions for erythema nodosum leprosum. Cochrane Database Syst Rev (2009) 0.88
Perceptions on the effectiveness of treatment and the timeline of Buruli ulcer influence pre-hospital delay reported by healthy individuals. PLoS Negl Trop Dis (2013) 0.88
Low but sufficient anidulafungin exposure in critically ill patients. Antimicrob Agents Chemother (2013) 0.87
Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic. Clin Diagn Lab Immunol (2004) 0.87
Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response. Antimicrob Agents Chemother (2014) 0.87
Understanding and tackling health-related stigma. Psychol Health Med (2006) 0.87
Cardiac troponin I release and cytokine response during experimental human endotoxaemia. Intensive Care Med (2003) 0.87
Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection. Curr Pharm Des (2011) 0.85
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole. Antimicrob Agents Chemother (2013) 0.85
Unusual cluster of HIV type 1 dual infections in Groningen, The Netherlands. AIDS Res Hum Retroviruses (2010) 0.85
Drug concentration in lung tissue in multidrug-resistant tuberculosis. Eur Respir J (2013) 0.84
Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India. PLoS Negl Trop Dis (2011) 0.84
Pandemic influenza and excess intensive-care workload. Emerg Infect Dis (2008) 0.84
Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Respir Med (2006) 0.84
The meaning of leprosy and everyday experiences: an exploration in cirebon, indonesia. J Trop Med (2013) 0.82
Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients. PLoS Negl Trop Dis (2013) 0.81
Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity. Br J Nutr (2010) 0.81
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease. Ther Drug Monit (2015) 0.80
Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis. Ther Drug Monit (2011) 0.80
Automated erythrocytapheresis in severe falciparum malaria: A critical appraisal. Acta Trop (2006) 0.80
Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia. Emerg Infect Dis (2007) 0.80
Disability and leprosy: the way forward. Ann Acad Med Singapore (2007) 0.79
Patient and provider perspectives on HIV and HIV-related stigma in Dutch health care settings. AIDS Patient Care STDS (2014) 0.78
Physicians' and nurses' opinions on selective decontamination of the digestive tract and selective oropharyngeal decontamination: a survey. Crit Care (2010) 0.76
Children with leprosy. Lepr Rev (2014) 0.76
A systematic review of a single-class maintenance strategy with nucleoside/nucleotide reverse transcriptase inhibitors in HIV/AIDS. Antivir Ther (2014) 0.76
Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection. Am J Trop Med Hyg (2013) 0.76
D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med (2011) 0.76
Corticosteroids for patients with septic shock. JAMA (2003) 0.75
Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med (2003) 0.75
Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit. Crit Care Med (2003) 0.75
The African challenge. Lancet (2002) 0.75
Unraveling the mystery of adrenal failure in the critically ill. Crit Care Med (2004) 0.75
Disclosure of HIV Status to Health Care Providers in the Netherlands: A Qualitative Study. J Assoc Nurses AIDS Care (2016) 0.75
Infection of great apes and a zoo keeper with the same Mycobacterium tuberculosis spoligotype. Med Microbiol Immunol (2013) 0.75
[A sore throat: tumour, tuberculosis or both?]. Ned Tijdschr Geneeskd (2015) 0.75
Buruli ulcer and schistosomiasis: no association found. Am J Trop Med Hyg (2004) 0.75
[An asylum seeker with an abnormal chest X-ray]. Ned Tijdschr Geneeskd (2016) 0.75
Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events. AIDS (2016) 0.75
Lung transplantation for acute respiratory failure in rapidly progressive idiopathic pulmonary fibrosis. Transpl Int (2005) 0.75
Long-term follow-up of ROM treated cases. Lepr Rev (2007) 0.75
Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results. AIDS Patient Care STDS (2010) 0.75
Availability of drugs to admitted patients in Yemeni public hospitals. Eur J Clin Pharmacol (2002) 0.75
Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care. Ther Drug Monit (2016) 0.75
p38-MAPK inhibition and endotoxin induced tubular dysfunction in men. J Endotoxin Res (2004) 0.75